This Cochrane Review evaluated whether more patient‐friendly alternative regimens are as efficacious as the standard regimen for radical cure ofP vivax malaria.
The malaria vector Anopheles stephensi is found in wide tracts of Asia and the Middle East.
The Centre for Research in Medical Entomology (CRME), Madurai, India is going to host a Global Exchange Lecture Course funded by the European Molecular Biology Organization (EMBO) from 29 January to 11 February, 2017. The details about this course can be found at: http://events.embo.org/17-malaria/
Formal/informal inquiries can be made by sending an email to: embomadurai2017@gmail.com
Amongst several communicable diseases (CDs), malaria is one of the deadliest parasitic disease all over the world, particularly in African and Asian countries.
The present study represents the first global characterization of An. anthropophagus miRNAs in sexual differences and stage-specific functions.
All respondents report conducting case investigation as part of surveillance activities. More than half of these countries conduct investigations for each case. Over half aim to accomplish the investigation within one to two days of a case report.
This approach will address the malaria problem in a collective manner so that malaria control can be sustained over time.
This study suggests that maintaining a vigilant surveillance system, environmental management, vector-control efforts, and case management are needed to prevent outbreaks and sustain the eradication of malaria in Taiwan.
Fungal isolates showed a range of virulence to A. stephensi with some causing >80% mortality within 7 days, while others caused little increase in mortality relative to controls over the study period.
In three independent studies, we observed strong associations between SAO and protection against P. vivax malaria by a mechanism that is independent of the Duffy antigen. P. vivax malaria may have contributed to shaping the unique host genetic adaptations to malaria in Asian and Oceanic populations.
